Yang Chenglin,Li Jianbin,Wang Wei.Sequence selection of postoperative radiotherapy and systemic treatment for breast cancer patients[J].Chinese Journal of Radiological Medicine and Protection,2021,41(10):790-795
Sequence selection of postoperative radiotherapy and systemic treatment for breast cancer patients
Received:March 17, 2021  
DOI:10.3760/cma.j.issn.0254-5098.2021.10.012
KeyWords:Breast cancer  Postoperative radiotherapy  Postoperative systemic therapy  Sequence selection
FundProject:山东省自然科学基金(ZR2020QH260);国家自然科学基金青年基金(81703038)
Author NameAffiliationE-mail
Yang Chenglin Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China  
Li Jianbin Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China  
Wang Wei Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300070, China w.wei1103@163.com 
Hits: 1912
Download times: 800
Abstract::
      The role of postoperative adjuvant therapy is crucial for breast cancer. Also, there is no doubt that the combination of effective postoperative radiotherapy and adjuvant systemic therapy can not only reduce the local recurrence rate, but also improve the survival rate of patients. Although the timing of postoperative radiotherapy and part of systemic therapy is clear, some part of treatment regimens still remain elusive. In particular, the safety of concurrent therapy of postoperative consolidation chemotherapy and postoperative radiotherapy in patients with neoadjuvant chemotherapy, the safety of concurrent therapy of postoperative dual-targeted therapy and postoperative radiotherapy in HER2-positive patients, and the safety of simultaneous radiotherapy of small molecule inhibitors need to be further clarified. This article reviews the related papers on the sequence selection of postoperative radiotherapy and postoperative adjuvant systemic therapy for breast cancer.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061271  On-line:0

v
Scan QR Code
&et=40B975F5DE2E0CB4D9350101C4AB9B497D94570A9841754D9290A1F3053BB696CDCBFE212AD100145E95B71DCFF616F57D36A236F17B44707EC53C03E4194D8654D212CDC49758DD3E292666CBCFF70A2DAC3912F51ACC225D11FA9AEFC1111F494174A88A555F31&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9475FABC7A03F4AB&aid=11709EAE29D30158B6F8B5ABED56234D&vid=&iid=F3090AE9B60B7ED1&sid=C8C16F05E379B334&eid=FC6FCA5A7559F1FB&fileno=20211012&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9475FABC7A03F4AB"; var my_aid="11709EAE29D30158B6F8B5ABED56234D";